Cat: IPD-X41167

Recombinant Influenza A virus X477S Protein ,His & Myc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    X477S

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    Nucleocapsid protein;Nucleocapsid protein;Protein N

  • 种属

    Influenza A virus

  • 表达系统

    E. coli

  • 标签

    N- His & C- Myc

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    A0A6G5UZV1

  • 表达区间

    1-498aa(X477S)

  • 分子量

    63.4 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

The X477S recombinant protein has emerged as a focal point of research due to its potential applications in various biotechnological and biomedical fields. Derived from engineered variants of existing proteins, X477S exhibits unique structural and functional properties that may enhance its utility in therapeutic and industrial processes. Researchers are particularly intrigued by its role in the modulation of specific biological pathways, which could lead to advancements in drug development, particularly for diseases caused by protein misfolding and aggregation. The development of X477S involves intricate techniques such as site-directed mutagenesis and advanced purification methods, enabling scientists to study its interactions at a molecular level. Additionally, preliminary studies have suggested that X477S may possess enhanced stability and activity compared to its wild-type counterparts, making it a promising candidate for further investigation. As research progresses, the implications of X477S in protein engineering, therapeutic interventions, and its potential to serve as a model for understanding protein dynamics are being explored, highlighting the importance of this recombinant protein in modern scientific inquiry.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US